Why the spastic hand after stroke needs a structured plan
If a family member has had a stroke and the hand remains clenched, stiff or painful, you are likely looking for clear answers. Spasticity — the velocity-dependent increase in muscle tone that makes it difficult to open the hand or move the fingers — is one of the most common and frustrating sequelae of upper motor neurone syndrome. Two classic errors persist in clinical practice: treating spasticity as an isolated target (simply 'reducing tone') without defining a functional goal (hygiene, dressing, assisted grasp), and prescribing splints routinely without a clear therapeutic plan. Current clinical practice guidelines agree: management must be goal-directed, multimodal and guided by explicit 'do' and 'don't' decisions.
First things first: spasticity or contracture?
Before selecting any intervention it is essential to distinguish between the two:
- Predominantly spasticity: Resistance varies: it changes with movement velocity, emotional state and posture. It can improve with appropriate positioning and active management. This is the component amenable to botulinum toxin type A and rehabilitation.
- Structural contracture: There is genuine loss of passive range of motion (soft-tissue shortening). It does not yield to a brief stretch. Strategies such as serial casting, appropriately prescribed orthoses or specific medical management are usually required.
Clinical tip: if you attempt to open the patient's hand slowly and it does not yield at all, contracture is likely already established. Generic resting hand splints rarely resolve this.
What WORKS (when appropriately indicated)
- Botulinum toxin type A (BoNT-A) for focal hand spasticity: This is the intervention most strongly supported by clinical practice guidelines for focal spasticity (localised hypertonia in wrist and finger flexors). It is injected into target muscles (finger flexors, wrist flexors, pronators) and reduces tone for several weeks, creating a therapeutic 'window' for task-oriented rehabilitation. The Royal College of Physicians (RCP) guidelines position BoNT-A within a comprehensive goal-directed programme. For optimal outcomes: define a measurable goal (palmar opening for hygiene, pain reduction, improved assisted grasp), select muscles using guided technique (ultrasound/EMG), and always combine with task-oriented rehabilitation and a home programme.
- Functional rehabilitation and goal-directed occupational therapy: This is the component that converts tone reduction into real-world improvement. It includes repetitive task-oriented training (opening the hand for hygiene, manipulating real objects, dressing) and proximal motor control work (scapula and shoulder) to 'free' the hand during daily activities. Key principle: botulinum toxin or any tone-management intervention without functional tasks = reduced transfer to real life.
- 24-hour positioning and care (especially in the early phase): Prevent the hand from remaining constantly clenched in flexion. Maintain hand hygiene (skin, nails, prevention of maceration between the fingers). This may seem basic, but effective positioning directly impacts pain and preservation of passive range of motion.
- Serial casting or appropriately prescribed orthoses when range is at risk: When the hand tends to close progressively, the goal is usually to preserve range of motion and facilitate hygiene or assisted function — not to 'create fine motor function from nothing'. Serial casts are applied in a staged manner to gain opening incrementally. Orthoses must have a clear goal within a multimodal plan.
- Intrathecal baclofen (ITB) for severe generalised spasticity: For severe spasticity affecting the entire body (not just the hand), intrathecal baclofen may be considered: a medication delivered directly into the spinal canal via an implanted pump. This is reserved for selected cases following specialist assessment.
What DOESN'T work (or 'not routinely') — avoiding wasted time and resources
- Routine use of resting hand splints: Best-practice guidelines (Stroke Foundation/Australia, Canadian Stroke Best Practices) state that resting hand/wrist splints should not be used routinely as they have not demonstrated improvements in function, pain or range of motion when applied without specific indication. This does not mean splints are useless: they are valuable when there is a specific goal (positioning, hygiene, deformity prevention, maximising the post-botulinum toxin window).
- Passive stretching as the sole intervention: Isolated stretching may provide transient relief but rarely changes hand function unless accompanied by sufficient practice dose, functional tasks and/or focal intervention such as botulinum toxin.
- 'Reduce tone at any cost': Reducing spasticity without a functional goal may worsen stability or weight-bearing capacity in some patients. The correct approach is 'useful tone': reduce what interferes and preserve what helps.
Quick clinical decision table: do and don't
GNeuro Protocol for Spastic Hand Post-Stroke (4 Steps)
Evidence Sources
Fuentes
- Royal College of Physicians (RCP): Spasticity management with BoNT-A guidelines
- Canadian Stroke Best Practices / Stroke Foundation: hand splints not recommended routinely
- Frontiers reviews on focal strategies (splinting/casting) in the post-stroke hand
- Clinical practice guidelines on intrathecal baclofen (ITB) for severe generalised spasticity
Request a hand and spasticity assessment + multimodal plan (BoNT-A + occupational therapy + tasks + transfer programme) at GNeuro.